Advertisement

The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus

Published:October 10, 2008DOI:https://doi.org/10.1016/j.ajog.2008.08.029

      Objective

      This study examined whether the type-5 phosphodiesterase inhibitor sildenafil citrate (Viagra; Pfizer, New York, NY) could increase uterine blood flow in intrauterine growth restriction (IUGR), thereby improving fetal oxygenation and well being.

      Study Design

      In fetal sheep, we induced IUGR at 105-110 days (0.7 gestation) using single umbilical artery ligation (SUAL). In SUAL and control animals, we measured uterine blood flow (UBF) and blood gases before and after sildenafil administration.

      Results

      SUAL fetuses were hypoxemic compared with controls. Following sildenafil, UBF was significantly decreased in both SUAL and control ewes for ∼40 minutes. In response to sildenafil, pO2 was decreased in SUAL and control fetuses and both groups displayed significant hypotension and tachycardia. At postmortem SUAL fetal body weight was significantly reduced by 23% compared with controls.

      Conclusion

      Sildenafil does not improve UBF or fetal well being in SUAL-induced IUGR pregnancies and should be used with caution in IUGR and healthy pregnancies because of its detrimental effects on uteroplacental perfusion and on the fetus.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marlow N.
        Paediatric implications—neonatal complications.
        in: Kingdom J. Baker P. Intrauterine growth restriction: aetiology and management. Springer, London2000: 337-349
        • Gagnon R.
        Placental insufficiency and its consequences.
        Eur J Obstet Gynecol Reprod Biol. 2003; 110: S99-S107
        • van Wassenaer A.
        Neurodevelopmental consequences of being born SGA.
        Pediatr Endocrinol Rev. 2005; 2: 372-377
        • Baschat A.A.
        Doppler application in the delivery timing of the preterm growth-restricted fetus: another step in the right direction.
        Ultrasound Obstet Gynecol. 2004; 23: 111-118
        • Roberts J.M.
        • Taylor R.N.
        • Musci T.J.
        • Rodgers G.M.
        • Hubel C.A.
        • McLaughlin M.K.
        Preeclampsia: an endothelial cell disorder.
        Am J Obstet Gynecol. 1989; 161: 1200-1204
        • Johnson M.R.
        • Anim-Nyame N.
        • Johnson P.
        • Sooranna S.R.
        • Steer P.J.
        Does endothelial cell activation occur with intrauterine growth restriction?.
        BJOG. 2002; 109: 836-839
        • Pinheiro da Costa B.E.
        • Scocco C.
        • Poli de Figueiredo C.E.
        • Guimaraes J.A.
        Increased serum phosphodiesterase activity in women with pre-eclampsia.
        BJOG. 2006; 113: 577-579
        • Briganti A.
        • Salonia A.
        • Deho F.
        • Zanni G.
        • Barbieri L.
        • Rigatti P.
        • Montorsi F.
        Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
        World J Urol. 2005; 23: 374-384
        • Wareing M.
        • Myers J.E.
        • O'Hara M.
        • et al.
        Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries.
        Am J Obstet Gynecol. 2004; 190: 1283-1290
        • Wareing M.
        • Myers J.E.
        • O'Hara M.
        • et al.
        Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia.
        Eur J Obstet Gynecol Reprod Biol. 2006; 127: 41-49
        • Supramaniam V.G.
        • Jenkin G.
        • Loose J.
        • Wallace E.M.
        • Miller S.L.
        Chronic fetal hypoxia increases activin A concentrations in the late-pregnant sheep.
        BJOG. 2006; 113: 102-109
        • Oyama K.
        • Padbury J.
        • Chappell B.
        • Martinez A.
        • Stein H.
        • Humme J.
        Single umbilical artery ligation-induced fetal growth retardation: effect on postnatal adaptation.
        Am J Physiol. 1992; 263: E575-E583
        • Resnik R.
        Intrauterine growth restriction.
        Obstet Gynecol. 2002; 99: 490-496
        • Miller S.L.
        • Chai M.
        • Loose J.
        • et al.
        The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus.
        Endocrinology. 2007; 148: 1288-1295
        • Miller S.L.
        • Jenkin G.
        • Walker D.W.
        Effect of nitric oxide synthase inhibition on the uterine vasculature of the late-pregnant ewe.
        Am J Obstet Gynecol. 1999; 180: 1138-1145
        • Noori S.
        • Friedlich P.
        • Wong P.
        • Garingo A.
        • Seri I.
        Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
        Neonatology. 2007; 91: 92-100
        • Leibovitch L.
        • Matok I.
        • Paret G.
        Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.
        Drugs. 2007; 67: 57-73
        • Villanueva-Garcia D.
        • Mota-Rojas D.
        • Hernandez-Gonzalez R.
        • et al.
        A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour.
        J Obstet Gynaecol. 2007; 27: 255-259
        • Nagdyman N.
        • Fleck T.
        • Bitterling B.
        • et al.
        Influence of intravenous sildenafil on cerebral oxygenation measured by near-infrared spectroscopy in infants after cardiac surgery.
        Pediatr Res. 2006; 59: 462-465
        • Coppage K.H.
        • Sun X.
        • Baker R.S.
        • Clark K.E.
        Expression of phosphodiesterase 5 in maternal and fetal sheep.
        Am J Obstet Gynecol. 2005; 193: 1005-1010
        • Zoma W.D.
        • Baker R.S.
        • Clark K.E.
        Effects of combined use of sildenafil citrate (Viagra) and 17beta-estradiol on ovine coronary and uterine hemodynamics.
        Am J Obstet Gynecol. 2004; 190: 1291-1297
        • Refuerzo J.S.
        • Sokol R.J.
        • Aranda J.V.
        • et al.
        Sildenafil citrate and fetal outcome in pregnant rats.
        Fetal Diagn Ther. 2006; 21: 259-263
        • Khan R.N.
        • Hamoud H.
        • Warren A.
        • Wong L.F.
        • Arulkumaran S.
        Relaxant action of sildenafil citrate (Viagra) on human myometrium of pregnancy.
        Am J Obstet Gynecol. 2004; 191: 315-321
        • Wareing M.
        • Myers J.E.
        • O'Hara M.
        • Baker P.N.
        Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction.
        J Clin Endocrinol Metab. 2005; 90: 2550-2555
        • Lumbers E.R.
        Effects of drugs on uteroplacental blood flow and the health of the foetus.
        Clin Exp Pharmacol Physiol. 1997; 24: 864-868
        • Greiss Jr, F.C.
        • Marston E.L.
        The uterine vascular bed: effect of estrogens during ovine pregnancy.
        Am J Obstet Gynecol. 1965; 93: 720-722
        • Lin C.S.
        • Lin G.
        • Xin Z.C.
        • Lue T.F.
        Expression, distribution and regulation of phosphodiesterase 5.
        Curr Pharm Des. 2006; 12: 3439-3457
        • Boyce E.G.
        • Umland E.M.
        Sildenafil citrate: a therapeutic update.
        Clin Ther. 2001; 23: 2-23
        • Hanson K.A.
        • Ziegler J.W.
        • Rybalkin S.D.
        • Miller J.W.
        • Abman S.H.
        • Clarke W.R.
        Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity.
        Am J Physiol. 1998; 275: L931-L941
        • Supramaniam V.G.
        • Jenkin G.
        • Wallace E.M.
        • O'Connor A.E.
        • de Kretser D.M.
        • Miller S.L.
        Effect of graded hypoxia on activin A, prostaglandin E2 and cortisol levels in the late-pregnant sheep.
        Reprod Fertil Dev. 2004; 16: 625-632
        • Giussani D.A.
        • Unno N.
        • Jenkins S.L.
        • et al.
        Dynamics of cardiovascular responses to repeated partial umbilical cord compression in late-gestation sheep fetus.
        Am J Physiol. 1997; 273: H2351-H2360